278 related articles for article (PubMed ID: 16282731)
41. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
42. [Three cases of giant rectal gastrointestinal stromal tumor].
Nakamoto K; Nagahara H; Noda E; Inoue T; Maeda K; Ohira G; Amano R; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1984-6. PubMed ID: 22202260
[TBL] [Abstract][Full Text] [Related]
43. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
El Hajj II; Chehal A; El Saghir NS
Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
[No Abstract] [Full Text] [Related]
44. [GIST: our experience].
Rossi MT; Fasano G; Morlino A; Scutari F
G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
[TBL] [Abstract][Full Text] [Related]
45. A case of hepatic metastasis from gastric GIST successfully resected following neoadjuvant targeted therapy.
Onoe S; Sakamoto Y
Jpn J Clin Oncol; 2011 Apr; 41(4):590. PubMed ID: 21447695
[No Abstract] [Full Text] [Related]
46. [A case of giant gastric GIST with multiple hepatic metastases with long-term survival after multimodal therapy].
Hara H; Takahashi T; Miyazaki Y; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2399-401. PubMed ID: 25731536
[TBL] [Abstract][Full Text] [Related]
47. [Curative resection for bulky gastrointestinal stromal tumor with conversion therapy by imatinib].
Nishimura T; Sakata K; Maeda Y; Nagashima Y; Okada T; Nakamura M; Setoguchi M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2202-4. PubMed ID: 22202330
[TBL] [Abstract][Full Text] [Related]
48. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance.
Gold JS; Dematteo RP
Ann Surg Oncol; 2007 Apr; 14(4):1247-8. PubMed ID: 17265116
[No Abstract] [Full Text] [Related]
49. The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor.
Wang JP; Wang T; Huang MJ; Wang L; Kang L; Wu XJ
Am J Clin Oncol; 2011 Jun; 34(3):314-6. PubMed ID: 20622646
[TBL] [Abstract][Full Text] [Related]
50. Small gastrointestinal stromal tumor of the stomach showing rapid growth and early metastasis to the liver.
Tanaka J; Oshima T; Hori K; Tomita T; Kim Y; Watari J; Oh K; Hirota S; Matsumoto T; Miwa H
Dig Endosc; 2010 Oct; 22(4):354-6. PubMed ID: 21175497
[TBL] [Abstract][Full Text] [Related]
51. [A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].
Nakatani K; Tanabe S; Nishimura K; Shimoda T; Azuma M; Katada C; Sasaki T; Higuchi K; Koizumi W; Saigenji K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):997-1000. PubMed ID: 16835496
[TBL] [Abstract][Full Text] [Related]
52. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].
Sassa M; Kobayashi Y; Sugeno H; Iwadate M; Suzuki S; Endo Y; Nakamura I; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2013 Jul; 40(7):937-41. PubMed ID: 23863741
[TBL] [Abstract][Full Text] [Related]
53. A resectable case of gastrointestinal stromal tumor derived from the rectal wall after oral targeted molecular therapy with imatinib mesylate.
Muramatsu T; Iida T; Hirasawa T; Kikuchi K; Yasui I; Murakami M; Yamashita E; Yasuda S; Kajiwara H; Yasuda M; Osamura RY; Mikami M
Tokai J Exp Clin Med; 2006 Sep; 31(3):87-90. PubMed ID: 21302230
[TBL] [Abstract][Full Text] [Related]
54. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
[TBL] [Abstract][Full Text] [Related]
55. Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome.
Machado NO; Chopra PJ; Al-Haddabi IH; Al-Qadhi H
JOP; 2011 Mar; 12(2):194-9. PubMed ID: 21386652
[TBL] [Abstract][Full Text] [Related]
56. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment].
Toyokawa T; Teraoka H; Kitayama K; Nomura S; Kanehara I; Nishino H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287
[TBL] [Abstract][Full Text] [Related]
57. [A Case of Laparoscopic Gastrectomy for Gastric GIST after Neoadjuvant Chemotherapy with Imatinib Mesylate].
Iwanaga T; Yamamoto S; Tsukamoto Y; Hamaguchi H; Katsumori T; Ohshima H
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1950-2. PubMed ID: 26805227
[TBL] [Abstract][Full Text] [Related]
58. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
Wan DS; Wu XJ; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Ding PR
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3064-7. PubMed ID: 17288838
[TBL] [Abstract][Full Text] [Related]
59. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
60. Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
Colović R; Micev M; Matić S; Colović N; Grubor N; Atkinson HD
Vojnosanit Pregl; 2013 Feb; 70(2):225-8. PubMed ID: 23607193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
